Bulis Veronica Sanchez 4
4 · Lyell Immunopharma, Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Bulis Veronica Sanchez
VP, Corporate Controller
Transactions
- Sale
Common Stock
2025-11-10$16.10/sh−239$3,848→ 9,213 total
Footnotes (2)
- [F1]Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
- [F2]The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $16.08 to $16.11 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.